We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Analysis & Separations

Stay up to date on the topics that matter to you

Asimov

Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.

Latest Asimov Content

Product News

Asimov Achieves 10x Improvement in Lentiviral Production, Launches New Stable Cell Line Development Service

Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes. Fully stable cell lines have all viral genes and transgene stably integrated.

Never miss a story

with the Breaking Science News daily newsletter